These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
728 related items for PubMed ID: 3900245
21. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies. Narayanan RB, Ramu G, Sinha S, Sengupta U, Malaviya GN, Desikan KV. Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852 [Abstract] [Full Text] [Related]
22. IL-7 in the cell-mediated immune response to a human pathogen. Sieling PA, Sakimura L, Uyemura K, Yamamura M, Oliveros J, Nickoloff BJ, Rea TH, Modlin RL. J Immunol; 1995 Mar 15; 154(6):2775-83. PubMed ID: 7876548 [Abstract] [Full Text] [Related]
23. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Brett SJ, Kingston AE, Colston MJ. Clin Exp Immunol; 1987 Jun 15; 68(3):510-20. PubMed ID: 3308217 [Abstract] [Full Text] [Related]
24. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients. Bach MA, Wallach D, Flageul B, Cottenot F. Clin Exp Immunol; 1983 Apr 15; 52(1):107-14. PubMed ID: 6345031 [Abstract] [Full Text] [Related]
25. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies. Narayanan RB, Bhutani LK, Sharma AK, Nath I. Clin Exp Immunol; 1983 Mar 15; 51(3):421-9. PubMed ID: 6342880 [Abstract] [Full Text] [Related]
26. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Ottenhoff TH, Elferink DG, Klatser PR, de Vries RR. Nature; 1983 Mar 15; 322(6078):462-4. PubMed ID: 2426597 [Abstract] [Full Text] [Related]
27. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin. Barnass S, Mace J, Steele J, Torres P, Gervasoni B, Ravioli R, Terencio J, Rook GA, Waters MF. Clin Exp Immunol; 1986 Apr 15; 64(1):41-9. PubMed ID: 2426020 [Abstract] [Full Text] [Related]
28. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Chattree V, Khanna N, Rao DN. Mol Immunol; 2007 Mar 15; 44(8):2066-77. PubMed ID: 17046060 [Abstract] [Full Text] [Related]
29. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy. Hussain R, Dockrell HM, Chiang TJ. Immunology; 1994 Nov 15; 83(3):495-500. PubMed ID: 7835976 [Abstract] [Full Text] [Related]
30. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL, Kato H, Mehra V, Nelson EE, Fan XD, Rea TH, Pattengale PK, Bloom BR. Nature; 1994 Nov 15; 322(6078):459-61. PubMed ID: 2942780 [Abstract] [Full Text] [Related]
31. Suppressor T lymphocytes from lepromatous leprosy skin lesions. Modlin RL, Mehra V, Wong L, Fujimiya Y, Chang WC, Horwitz DA, Bloom BR, Rea TH, Pattengale PK. J Immunol; 1986 Nov 01; 137(9):2831-4. PubMed ID: 2944966 [Abstract] [Full Text] [Related]
32. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Misra N, Murtaza A, Walker B, Narayan NP, Misra RS, Ramesh V, Singh S, Colston MJ, Nath I. Immunology; 1995 Sep 01; 86(1):97-103. PubMed ID: 7590888 [Abstract] [Full Text] [Related]
33. Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae. Haregewoin A, Mustafa AS, Helle I, Waters MF, Leiker DL, Godal T. Immunol Rev; 1984 Aug 01; 80():77-86. PubMed ID: 6386665 [Abstract] [Full Text] [Related]
34. T cells bearing V beta 6 T cell receptors in the cell-mediated immune response to Mycobacterium leprae. Wang X, Golkar L, Uyemura K, Ohmen JD, Villahermosa LG, Fajardo TT, Cellona RV, Walsh GP, Modlin RL. J Immunol; 1993 Dec 15; 151(12):7105-16. PubMed ID: 8258714 [Abstract] [Full Text] [Related]
35. An analysis of in vitro T cell responsiveness in lepromatous leprosy. Kaplan G, Weinstein DE, Steinman RM, Levis WR, Elvers U, Patarroyo ME, Cohn ZA. J Exp Med; 1985 Sep 01; 162(3):917-29. PubMed ID: 3928804 [Abstract] [Full Text] [Related]
36. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders. Thole JE, Janson AA, Kifle A, Howe RC, McLean K, Nurilygn A, Filley E, Shannon EJ, Bulla GJ, Hermans J. Int J Lepr Other Mycobact Dis; 1995 Sep 01; 63(3):369-80. PubMed ID: 7594920 [Abstract] [Full Text] [Related]
37. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS. Int J Lepr Other Mycobact Dis; 1996 Sep 01; 64(3):257-67. PubMed ID: 8862259 [Abstract] [Full Text] [Related]
38. In vitro studies on dermal granulomas of human leprosy: characterization of cells using monoclonal antibodies. Narayanan RB, Girdhar BK, Lavania RK, Sengupta U. Int J Lepr Other Mycobact Dis; 1986 Jun 01; 54(2):268-72. PubMed ID: 3088184 [Abstract] [Full Text] [Related]
39. In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Modlin RL, Gebhard JF, Taylor CR, Rea TH. Clin Exp Immunol; 1983 Jul 01; 53(1):17-24. PubMed ID: 6223731 [Abstract] [Full Text] [Related]
40. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum. Modlin RL, Mehra V, Jordan R, Bloom BR, Rea TH. J Immunol; 1986 Feb 01; 136(3):883-6. PubMed ID: 2416837 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]